Brokers Issue Forecasts for MOH FY2028 Earnings

Molina Healthcare, Inc (NYSE:MOH) – Analysts at Zacks Research issued their FY2028 EPS estimates for shares of Molina Healthcare in a report issued on Thursday, February 26th. Zacks Research analyst Team anticipates that the company will post earnings of $12.32 per share for the year. The consensus estimate for Molina Healthcare’s current full-year earnings is $24.40 per share.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings results on Thursday, February 5th. The company reported ($2.75) EPS for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The firm had revenue of $11.38 billion for the quarter, compared to analyst estimates of $10.90 billion. During the same quarter in the prior year, the business posted $5.05 EPS. The firm’s quarterly revenue was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS.

A number of other equities analysts have also recently weighed in on the company. UBS Group reaffirmed a “neutral” rating and issued a $145.00 price target on shares of Molina Healthcare in a report on Monday, February 9th. Jefferies Financial Group set a $160.00 price objective on Molina Healthcare in a research report on Tuesday, December 16th. Wells Fargo & Company set a $141.00 target price on Molina Healthcare and gave the company an “equal weight” rating in a research report on Friday, February 20th. Barclays dropped their price target on shares of Molina Healthcare from $164.00 to $133.00 and set an “underweight” rating on the stock in a research note on Tuesday, February 10th. Finally, The Goldman Sachs Group reduced their price objective on shares of Molina Healthcare from $167.00 to $124.00 and set a “neutral” rating for the company in a research report on Wednesday, February 11th. Two analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $157.86.

Molina Healthcare Trading Up 0.4%

MOH stock opened at $146.16 on Friday. Molina Healthcare has a 52-week low of $121.06 and a 52-week high of $359.97. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.97. The firm has a market cap of $7.53 billion, a P/E ratio of 17.07 and a beta of 0.49. The company’s 50-day simple moving average is $168.04 and its 200-day simple moving average is $168.63.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the company. Torren Management LLC acquired a new stake in Molina Healthcare during the 4th quarter worth $26,000. Miller Global Investments LLC purchased a new position in shares of Molina Healthcare in the fourth quarter worth about $27,000. Cromwell Holdings LLC boosted its position in Molina Healthcare by 211.9% during the fourth quarter. Cromwell Holdings LLC now owns 184 shares of the company’s stock worth $32,000 after acquiring an additional 125 shares during the last quarter. Quarry LP acquired a new position in Molina Healthcare during the fourth quarter worth about $32,000. Finally, First Horizon Advisors Inc. grew its stake in Molina Healthcare by 2,140.0% during the 2nd quarter. First Horizon Advisors Inc. now owns 112 shares of the company’s stock valued at $33,000 after acquiring an additional 107 shares in the last quarter. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.